Skip to main content

MedCloud Minute

Blog archive

Fuse Oncology Launches Platform to Streamline Radiation Therapy Workflows

Key Takeaways

  • Fuse Oncology launches FuseRx to streamline radiation oncology workflows with a unified cloud-based AI platform.
  • FuseRx accelerates radiation therapy by connecting scheduling, treatment planning, care coordination, and clinical documentation.
  • Cloud platform improves oncology collaboration with integrated workflows and evidence-based radiation treatment management.

Fuse Oncology, the structured AI platform for radiation oncology, has introduced FuseRx, a cloud-based platform designed to streamline radiation oncology workflows by connecting clinical, administrative, and treatment planning processes in a single system. FuseRx is the keystone of the Fuse platform, connecting the consult to simulation, planning, and treatment.

The platform is intended to reduce the time between a patient's initial consultation and the start of radiation therapy by centralizing scheduling, care coordination, treatment documentation and operational workflows. FuseRx also integrates with existing oncology systems, enabling care teams to access patient information and manage treatment activities without relying on multiple disconnected applications. The platform is built to support clinical pathways at the point of prescribing, whether institution-specific protocols or published evidence-based guidelines.

Fuse Oncology said the platform is designed to help cancer centers improve operational efficiency while supporting collaboration among physicians, dosimetrists, radiation therapists and administrative staff throughout the treatment process. FuseRx will make its public debut at the 68th AAPM Annual Meeting & Exhibition, July 19–22 in Vancouver, B.C.

Posted by MedCloudInsider Editors on 07/21/2026